ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P TSX Capped Composite...
43.02
0.26%
US Tech 100
22,232.00
0.63%
S&P 500
6,263.26
0.61%
US Dollar vs CAD
1.36824
-0.04%
Bitcoin
111,287.78
0.00%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Avant Technologies Inc (QB) (AVAI) Share Price

Avant Technologies Inc (QB)

Avant Technologies Inc (QB) (AVAI)

USOTC
0.5358
-0.0302
(-5.34%)
Closed July 09 3:00PM
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.5358
( -5.34% )
Bid
0.51
Ask
0.5942
Volume
134,589
0.507 Day's Range 0.5699
0.2191 52 Week Range 1.03
Market Cap
73.475M
Previous Close
0.566
Open
0.5688
Last Trade
2000
@
0.5358
Last Trade Time
Financial Volume
US$ 73,150
VWAP
0.543505
Average Volume (3m)
131,220
Shares Outstanding
137,131,580
Dividend Yield
-
PE Ratio
-34.84
Earnings Per Share (EPS)
-0.02
Revenue
-
Net Profit
-2.13M

About Avant Technologies Inc (QB)

Trend Innovations Holding, Inc. specializes in acquiring, creating, and developing innovative and advanced technologies that utilize artificial intelligence (AI), including software and other applications developed using the company's signature machine and deep-learning AI technology, Avant! AI. Tre... Trend Innovations Holding, Inc. specializes in acquiring, creating, and developing innovative and advanced technologies that utilize artificial intelligence (AI), including software and other applications developed using the company's signature machine and deep-learning AI technology, Avant! AI. Trend Innovations Holding's mission is to introduce AI to a host of industries, and shape how we engage with and implement AI technologies globally. Our strategy is three-fold. First, we create and introduce our own first-in-class AI-related technologies in-house, second, we offer Avant! AI as a business-to-business solution for customers to improve their own products with an AI enhancement, and finally, we license our sophisticated AI engine to third-party developers as a software development kit (SDK) to create and launch their own brand of AI-centric products. Show more

Sector
Cmp Processing,data Prep Svc
Industry
Cmp Processing,data Prep Svc
Website
www.avanttechnology.com
Headquarters
Las Vegas, Nevada, USA
Founded
-
Avant Technologies Inc (QB) is listed in the Cmp Processing,data Prep Svc sector of the OTCMarkets with ticker AVAI. The last closing price for Avant Technologies (QB) was US$0.57. Over the last year, Avant Technologies (QB) shares have traded in a share price range of US$ 0.2191 to US$ 1.03.

Avant Technologies (QB) currently has 137,131,580 shares outstanding. The market capitalization of Avant Technologies (QB) is US$77.62 million. Avant Technologies (QB) has a price to earnings ratio (PE ratio) of -34.84.

Ask ADVFN Intelligence (AI)

AVAI Latest News

More News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
July 08 2025
AVAI (-5.34%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
AVAI (-5.34%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0942-14.95238095240.630.637840.51616080.56446184CS
4-0.1642-23.45714285710.70.730.51713230.60485882CS
120.165844.81081081080.370.82770.321312200.62171513CS
260.083818.53982300880.4520.840.21911030520.58191714CS
52-0.2643-33.03337082860.80011.030.2191683840.57907812CS
156-0.9982-65.07170795311.5341.980.0645505980.67684227CS
260-0.9982-65.07170795311.5341.980.0645505980.67684227CS

AVAI - Frequently Asked Questions (FAQ)

What is the current Avant Technologies (QB) share price?
The current share price of Avant Technologies (QB) is US$ 0.5358
How many Avant Technologies (QB) shares are in issue?
Avant Technologies (QB) has 137,131,580 shares in issue
What is the market cap of Avant Technologies (QB)?
The market capitalisation of Avant Technologies (QB) is USD 77.62M
What is the 1 year trading range for Avant Technologies (QB) share price?
Avant Technologies (QB) has traded in the range of US$ 0.2191 to US$ 1.03 during the past year
What is the PE ratio of Avant Technologies (QB)?
The price to earnings ratio of Avant Technologies (QB) is -34.84
What is the reporting currency for Avant Technologies (QB)?
Avant Technologies (QB) reports financial results in USD
What is the latest annual profit for Avant Technologies (QB)?
The latest annual profit of Avant Technologies (QB) is USD -2.13M
What is the registered address of Avant Technologies (QB)?
The registered address for Avant Technologies (QB) is 5348 VEGAS DRIVE, LAS VEGAS, NEVADA, 89108
What is the Avant Technologies (QB) website address?
The website address for Avant Technologies (QB) is www.avanttechnology.com
Which industry sector does Avant Technologies (QB) operate in?
Avant Technologies (QB) operates in the CMP PROCESSING,DATA PREP SVC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PGTKPacific Green Technologies Inc New (CE)
US$ 0.50
(99,900.00%)
260
BJURFBonjour Holdings Limited (PK)
US$ 0.03
(29,900.00%)
100
AFIBAcutus Medical Inc (CE)
US$ 0.0002
(19,900.00%)
1.62M
PIKMKidpik Corporation (CE)
US$ 0.0111
(11,000.00%)
1.03k
TMSHTransGlobal Assets Inc (PK)
US$ 0.0001
(9,900.00%)
1.24M
ZHCLFZenith Capital Corporation (CE)
US$ 0.0001
(-99.80%)
17.65k
ARVLFArrival (CE)
US$ 0.000001
(-99.67%)
155
TCCOTechnical Communications Corp (CE)
US$ 0.0002
(-99.33%)
1.35k
MRNJMetatron Inc (PK)
US$ 0.000001
(-99.00%)
5.48M
GEGPGold Entertainment Group Inc (PK)
US$ 0.000001
(-99.00%)
1.86M
HMBLHUMBL Inc (PK)
US$ 0.0002
(-33.33%)
793.29M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
142.47M
DPLSDarkPulse Inc (PK)
US$ 0.0004
(0.00%)
139.84M
BFCHBitFrontier Capital Holdings Inc (PK)
US$ 0.0004
(-42.86%)
129M
DRNKNoHo Inc (PK)
US$ 0.0004
(0.00%)
106.12M

AVAI Discussion

View Posts
pumper_stumper pumper_stumper 8 hours ago
Beware of the paid promotion here folks! When you see these clear signs (and yes, they are promoting this, for sure), it tells you the company is a scam, pure and simple!
👍️0
resx18 resx18 2 weeks ago
Avant Technologies (OTCQB: AVAI) withdrew its currently pending Form S-1

Termination of a Material Definitive Agreement

The Company withdrew its currently pending Form S-1 registration statement and pursue a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share. This new structure will be designed to better reflect prevailing market conditions, enhance compliance with applicable regulations, and support transparent corporate governance.

https://www.otcmarkets.com/filing/html?id=18457568&guid=Pdi-kp4gOAIqJth
👍️0
Cameo Brien Cameo Brien 2 weeks ago
$AVAI Focused on AI and healthcare tech: IT consulting, AI-enabled health products (e.g., Thy News app, healthcare AI platform)  
Engaged in key partnerships and projects:
Formed a joint venture with Ainnova for diabetic retinopathy screening, vision-AI, dementia detection & automated retinal cameras  
Signed a Letter of Intent on June 10, 2025, and expanding Latin American reach  
👍️0
resx18 resx18 2 weeks ago
Good Morning $AVAI
👍️0
Cameo Brien Cameo Brien 2 weeks ago
☕️ 
👍️0
Cameo Brien Cameo Brien 2 weeks ago
Battling here
👍️0
resx18 resx18 2 weeks ago
$AVAI News:
👍 1
resx18 resx18 2 weeks ago
Good Morning $AVAI
👍️0
Cameo Brien Cameo Brien 2 weeks ago
Break the 60s
👍️0
Cameo Brien Cameo Brien 2 weeks ago
Good eod push
👍️0
resx18 resx18 2 weeks ago
$AVAI - Avant Technologies Creating New Company for Expansion of Diabetes Program
Avant Technologies Creating New Company for Expansion of Diabetes Program PR Newswire LAS VEGAS , June 24, 2025
👍 1
Cameo Brien Cameo Brien 2 weeks ago
Moving up
👍️0
resx18 resx18 2 weeks ago
💪 $AVAI a Vision for the Future 💪

Avant’s proactive approach—combining AI-driven diagnostics with biotech-driven treatments—sets it apart in the healthcare technology space. The new company will streamline efforts to innovate and commercialize solutions, building on Avant’s existing partnerships with industry leaders like Roche and Apollo Hospitals. By addressing both prevention and treatment, Avant is poised to become a key player in global diabetes care.


🚀 The Bottom Line 🚀

Avant Technologies (OTCQB: $AVAI) is making bold moves to redefine diabetes management, from early detection with Vision AI to potential treatments through its new company. With a scalable platform, strategic partnerships, and a clear vision for growth, AVAI is an under-the-radar stock with breakout potential. Investors looking for exposure to AI and biotech innovation should keep AVAI on their radar.
👍️0
resx18 resx18 2 weeks ago
Good Morning $AVAI
👍 1
Cameo Brien Cameo Brien 2 weeks ago
More today? 
👍️0
resx18 resx18 2 weeks ago
This merger makes sense. $AVAI
👍️0
Cameo Brien Cameo Brien 2 weeks ago
Good base here
👍️0
resx18 resx18 2 weeks ago
Avant Technologies and their joint venture partner Ainnova Tech are building their technology portfolio through their AI-driven Vision AI platform, with a focus on making early disease detection more accessible and affordable.$AVAI
👍️0
resx18 resx18 2 weeks ago
$AVAI to $1 land
👍 1
Cameo Brien Cameo Brien 2 weeks ago
Volume growing here
👍️ 1
Cameo Brien Cameo Brien 2 weeks ago
Green $AVAI
👍️0
resx18 resx18 2 weeks ago
4 AI algorithms (cardiovascular, diabetes, liver fibrosis, CKD) validated across diverse populations
Pilot program via Roche in Costa Rica for diabetic retinopathy detection; expandable to other regions
👍️0
resx18 resx18 2 weeks ago
Avant expects that a new relationship will allow it to expand its diabetes program to both identify the early markers of the disease and to treat diabetes.
👍️0
resx18 resx18 2 weeks ago
Avant's Chief Executive Officer, Chris Winter, said, "It is the work we're doing with Ainnova to screen diabetes patients to identify the early signs of diabetic retinopathy that is driving Avant to contribute even more to the fast-growing disease - a potential treatment. We are exploring several promising opportunities to get involved in the development of a treatment for diabetes globally, and if successful, we want to be ready to hit the ground running with the formation of a company to house that opportunity."
👍️0
resx18 resx18 2 weeks ago
$AVAI - Avant Technologies Creating New Company for Expansion of Diabetes Program
https://marketwirenews.com/news-releases/avant-technologies-creating-new-company-for-expansio-8368341234318225.html
👍 1
resx18 resx18 2 weeks ago
Good Morning $AVAI
👍 1
Cameo Brien Cameo Brien 2 weeks ago
$AVAI
https://marketwirenews.com/news-releases/avant-technologies-creating-new-company-for-expansio-8368341234318225.html
👍 1
Cameo Brien Cameo Brien 2 weeks ago
Current Price: ~$0.58 (as of June 23, 2025)  
52-Week Range: $0.22 – $1.05  
Market Cap: Approximately $75–80?million  
Average Daily Volume: ~150,000 shares  
Real-time Volatility & Movers: +7–12% intraday moves not uncommon 
👍 1
Cameo Brien Cameo Brien 2 weeks ago
Partnerships:
Exclusive license for 4 AI algorithms (cardiovascular, diabetes, liver fibrosis, CKD) validated across diverse populations 
Pilot program via Roche in Costa Rica for diabetic retinopathy detection; expandable to other regions
👍️0
Cameo Brien Cameo Brien 2 weeks ago
✅ Why It MattersRegulatory Catalyst: FDA pre-submission in July?2025 could swing investor sentiment.
Real-World Traction: Pilots in LATAM show viable business uptake ahead of U.S. roll-out.
Clear Market Growth: Positioned in the accelerating AI-healthcare diagnostics space.
👍️0
Cameo Brien Cameo Brien 2 weeks ago
.
🔍 What to Monitor NextDate EventJuly 7, 2025 FDA pre-submission meeting feedbackOngoing Clinical pilot expansion performance & data readoutsRegulatory Updates on 510(k) pathway and potential dementia module
👍️0
Brocool Brocool 2 weeks ago
Avant Technologies, Inc. serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.$AVAI
👍️0
Brocool Brocool 2 weeks ago
Avant Technologies, Inc.and partner, Ainnova Tech, Inc., announced that screenings for diabetic retinopathy begin this week in collaboration with Grupo Dökka and its leading pharmacy subsidiaries, Fischel Pharmacies and La Bomba Pharmacies located in Central America.$AVAI
👍 1
resx18 resx18 2 weeks ago
Joint venture partner Ainnova Tech are in negotiations!
👍 1
resx18 resx18 2 weeks ago
Should be a good day tomorrow. $AVAI
👍 1
Brocool Brocool 2 weeks ago
The companies have already integrated four algorithms through exclusive licensing and view retinal examination as a new vital sign, combined with laboratory tests and patient data for comprehensive health reporting.$AVAI
👍️0
Brocool Brocool 2 weeks ago
Avant Technologies and their joint venture partner Ainnova Tech are building their technology portfolio through their AI-driven Vision AI platform, with a focus on making early disease detection more accessible and affordable.$AVAI
👍️0
Brocool Brocool 2 weeks ago
Avant Technologies and its joint venture partner Ainnova Tech are in negotiations to license or acquire patented early disease detection technology from an international healthcare innovation company. The potential deal aims to enhance preventive health reporting capabilities and disease detection correlation without requiring complete patient data.$AVAI
👍️0
resx18 resx18 2 weeks ago
Grabbed a starter here. $AVAI
👍️0
resx18 resx18 2 weeks ago
Vinicio Vargas, Chief Executive Officer at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp., a joint venture company created by both Avant and Ainnova, said of the benefits for the collaboration, "As we begin similar initiatives in Mexico, our goal is to close the patient care loop with timely treatment—connecting every step of the journey. We are integrating pharma, retail, ophthalmologists, and our technology into a unified experience, all driven by one incentive: the well-being of the diabetic patient. Projects like this allow us to validate the model across diverse populations and sectors as part of our strategy to reach the market in a smarter, more efficient way—where the biggest winners are the patients."
👍️0
resx18 resx18 2 weeks ago
Nice day here $AVAI
💯 1
Cameo Brien Cameo Brien 2 weeks ago
Nibbling
👍️0
resx18 resx18 2 weeks ago
Why $AVAI is a Stock to Watch?

Massive Market Opportunity: The global diabetic retinopathy market is projected to grow at a 6.4% CAGR to 2030, while the broader AI healthcare market is expected to hit $200 billion. Avant’s Vision AI and retinal camera tap into these high-growth sectors.

FDA Catalyst: The upcoming FDA pre-submission meeting in July 2025 for Vision AI’s diabetic retinopathy trial could pave the way for 510(k) clearance, unlocking the lucrative U.S. market.

Speculative Upside: As an OTCQB stock, $AVAI offers significant growth potential for risk-tolerant investors, especially with its low-cost technology and strategic partnerships with industry leaders like Roche and Apollo Hospitals.

Scalable Platform: Vision AI’s ability to detect multiple diseases, paired with a cost-effective retinal camera, creates a versatile platform with applications across primary care, optometry, and pharmacies.
👍 1
resx18 resx18 2 weeks ago
The rollout also gives Avant a timely proof point as it moves to consolidate Vision AI under one roof. Earlier this month, the company signed a non-binding letter of intent to acquire 100% of Ainnova Tech—bringing leadership, data, and intellectual property together ahead of a scheduled FDA pre-submission meeting in July. Folding the joint venture into a single public entity would remove the current holding-company structure, streamlining everything from regulatory filings to revenue recognition. Management sees the unified cap table as a potential draw for both investors and strategic partners.
👍️ 1 ✔️ 1
resx18 resx18 2 weeks ago
One example is the rollout of AI-powered screenings for diabetic retinopathy now underway across Costa Rica, Nicaragua, and Panama. Avant Technologies, Inc. (OTCQB: AVAI) and joint-venture partner Ainnova Tech have begun offering free Vision AI scans inside Grupo Dökka's Fischel and La Bomba pharmacy chains.
👍️ 1 🤠 1
resx18 resx18 2 weeks ago
"As we begin similar initiatives in Mexico, our goal is to close the patient care loop with timely treatment, connecting every step of the journey," said Vinicio Vargas, CEO of Ainnova Tech and board member of Ai-nova Acquisition Corp. "We are integrating pharma, retail, ophthalmologists, and our technology into a unified experience, all driven by one incentive, the well-being of the diabetic patient."
👍 1 🥳 1
Cameo Brien Cameo Brien 2 weeks ago
Bids set
👍 1
resx18 resx18 2 weeks ago
Good Morning $AVAI
👍 1
Cameo Brien Cameo Brien 2 weeks ago
On the radar
👍 1
Banjo50 Banjo50 3 weeks ago
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0

Your Recent History

USOTC
AVAI
Avant Technologies (QB)
Delayed Upgrade Clock
ADVFN
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads